Clinical Trial Update: A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating AZT in HIV-infected patients with AIDS-related Kaposi's sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids-related Kaposi Sarcoma
• HIV Infections

Drugs mentioned

• AZT (zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED